Eden Innovations (ASX:EDE) Reports Growing US Project Pipeline for EdenCrete

Aditi Sarkar

27 October 2026 07:36 PM AEDT

Eden Innovations (ASX:EDE) Reports Growing US Project Pipeline for EdenCrete

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

EdenCrete products being used in a growing number of large US projects.
Pz7 to be used in about 15,000 cubic yards of concrete on the I-70 Floyd Hill project.
Colorado activity rising as early-adopter plants include Pz7 in mix designs.
Original EdenCrete seeing renewed use in high-durability applications.

Eden Innovations Ltd (ASX:EDE) has provided an update on its growing US project pipeline for EdenCrete, its range of nano-carbon-strengthened concrete additives. The company said its products are appearing in a growing number of large projects across several sectors and states, many of them supplied by ready-mix concrete plants that have installed EdenCrete Pz7.

How the Pipeline Is Building

Eden works with ready-mix concrete plants on mix design optimisation rather than promoting the product project by project. Once Pz7 is included in a mix design, it is applied automatically to every pour that uses that design.

The company describes each bulk storage and dispensing installation as a self-sustaining source of recurring demand. It said many Colorado plants were early Pz7 adopters, and the rising project count suggests the optimisation phase is complete.

Colorado Projects

Projects using Pz7 include the 16-storey Aliyah Apartments in Denver, which will use 24,000 cubic yards of concrete, and the 22-storey Block F high-rise at Bellview Station, using 25,000 cubic yards. Other projects include the Kairoi LoHi Townhomes, Pearl Street Residences, the Ernest rehabilitation hospital in Broomfield and Epicenter Phase 2 in Colorado Springs.

On the I-70 Floyd Hill project, a major highway upgrade with a 2025 cost estimate of US$905 million, Pz7 will be used in about 15,000 cubic yards of concrete for large columns.

Renewed Demand for Original EdenCrete

Original EdenCrete is being used for abrasion resistance and durability at a newly opened waste transfer station in North Pueblo, Colorado. In Georgia, all concrete for a new 450 cubic yard slab at the Atlantic Waste Transfer Station in Jessup will use EdenCrete, the second such facility to do so.

Eden reported a notable rise in requests from existing Pz7 customers to trial and use original EdenCrete. It views Colorado activity as a leading indicator for its broader North American installation base.

Key Takeaways

Eden's plant-based installation model is driving recurring EdenCrete demand.
Colorado projects show Pz7 moving into regular mix designs.
Infrastructure use includes the I-70 Floyd Hill highway project.
Interest in original EdenCrete is rising among existing customers.

FAQs

Q: What is EdenCrete?

A: EdenCrete is Eden's range of proprietary nano-carbon-strengthened concrete additives.

Q: How is Pz7 used in projects?

A: Once included in a ready-mix plant's mix design, Pz7 is applied automatically to every pour using that design.

Q: Which major infrastructure project is using Pz7?

A: The I-70 Floyd Hill project in Colorado will use Pz7 in about 15,000 cubic yards of concrete.

Q: Where is project activity growing most?

A: Colorado has seen the strongest growth in projects.

Q: Is original EdenCrete still in use?

A: Yes. It is being used in high-durability applications such as waste transfer station slabs.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.